Asymchem Laboratories Valero Bond
002821 Stock | 83.25 0.75 0.89% |
As of November 25, 2024, Long Term Debt is expected to decline to about 15 M. In addition to that, Short and Long Term Debt is expected to decline to about 11.6 M With a high degree of financial leverage come high-interest payments, which usually reduce Asymchem Laboratories' Earnings Per Share (EPS).
The current year's Total Current Liabilities is expected to grow to about 1.9 B, whereas Non Current Liabilities Total is forecasted to decline to about 270.1 M. Asymchem |
Given the importance of Asymchem Laboratories' capital structure, the first step in the capital decision process is for the management of Asymchem Laboratories to decide how much external capital it will need to raise to operate in a sustainable way. Once the amount of financing is determined, management needs to examine the financial markets to determine the terms in which the company can boost capital. This move is crucial to the process because the market environment may reduce the ability of Asymchem Laboratories Tian to issue bonds at a reasonable cost.
Popular Name | Asymchem Laboratories Valero Energy Partners |
Specialization | Pharmaceuticals, Biotechnology & Life Sciences |
Equity ISIN Code | CNE100002BZ6 |
Bond Issue ISIN Code | US91914JAA07 |
S&P Rating | Others |
Maturity Date | 15th of December 2026 |
Issuance Date | 9th of December 2016 |
Coupon | 4.375 % |
Asymchem Laboratories Outstanding Bond Obligations
Dana 575 percent | US235822AB96 | Details | |
Volcan Compania Minera | USP98047AC08 | Details | |
Boeing Co 2196 | US097023DG73 | Details | |
HSBC Holdings PLC | US404280DR76 | Details | |
MPLX LP 4875 | US55336VAG59 | Details | |
MPLX LP 4125 | US55336VAK61 | Details | |
MPLX LP 52 | US55336VAL45 | Details | |
International Game Technology | US460599AD57 | Details | |
BNP Paribas FRN | USF1R15XK367 | Details | |
Morgan Stanley 3971 | US61744YAL20 | Details | |
MGM Resorts International | US552953CD18 | Details | |
Valero Energy Partners | US91914JAA07 | Details | |
AerCap Global Aviation | US00773HAA59 | Details |
Understaning Asymchem Laboratories Use of Financial Leverage
Asymchem Laboratories' financial leverage ratio helps determine the effect of debt on the overall profitability of the company. It measures Asymchem Laboratories' total debt position, including all outstanding debt obligations, and compares it with Asymchem Laboratories' equity. Financial leverage can amplify the potential profits to Asymchem Laboratories' owners, but it also increases the potential losses and risk of financial distress, including bankruptcy, if Asymchem Laboratories is unable to cover its debt costs.
Last Reported | Projected for Next Year | ||
Long Term Debt | 17.9 M | 15 M | |
Short and Long Term Debt | 12.2 M | 11.6 M | |
Short Term Debt | 167.4 M | 148.8 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Asymchem Stock
Asymchem Laboratories financial ratios help investors to determine whether Asymchem Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Asymchem with respect to the benefits of owning Asymchem Laboratories security.
What is Financial Leverage?
Financial leverage is the use of borrowed money (debt) to finance the purchase of assets with the expectation that the income or capital gain from the new asset will exceed the cost of borrowing. In most cases, the debt provider will limit how much risk it is ready to take and indicate a limit on the extent of the leverage it will allow. In the case of asset-backed lending, the financial provider uses the assets as collateral until the borrower repays the loan. In the case of a cash flow loan, the general creditworthiness of the company is used to back the loan. The concept of leverage is common in the business world. It is mostly used to boost the returns on equity capital of a company, especially when the business is unable to increase its operating efficiency and returns on total investment. Because earnings on borrowing are higher than the interest payable on debt, the company's total earnings will increase, ultimately boosting stockholders' profits.Leverage and Capital Costs
The debt to equity ratio plays a role in the working average cost of capital (WACC). The overall interest on debt represents the break-even point that must be obtained to profitability in a given venture. Thus, WACC is essentially the average interest an organization owes on the capital it has borrowed for leverage. Let's say equity represents 60% of borrowed capital, and debt is 40%. This results in a financial leverage calculation of 40/60, or 0.6667. The organization owes 10% on all equity and 5% on all debt. That means that the weighted average cost of capital is (.4)(5) + (.6)(10) - or 8%. For every $10,000 borrowed, this organization will owe $800 in interest. Profit must be higher than 8% on the project to offset the cost of interest and justify this leverage.Benefits of Financial Leverage
Leverage provides the following benefits for companies:- Leverage is an essential tool a company's management can use to make the best financing and investment decisions.
- It provides a variety of financing sources by which the firm can achieve its target earnings.
- Leverage is also an essential technique in investing as it helps companies set a threshold for the expansion of business operations. For example, it can be used to recommend restrictions on business expansion once the projected return on additional investment is lower than the cost of debt.